Bupa clinic crosses line, reignites concerns over insurer ownership

Lynnette Hoffman

writer

Lynnette Hoffman

Managing Editor

Lynnette Hoffman

A practice manager at a Bupa-owned clinic told its GPs to ensure “revenue is increasing,” asking them to increase bookings for chronic disease management plans and rebook eligible patients for additional assessments that couldn’t be claimed on the same day, the ABC reported this week.

The news has rekindled concerns of conflict of interest at corporate clinics and potentially puts doctors at risk, as the Department of Health, Disability and Ageing named care and management plans as a 2026 compliance priority, with claims for these items being monitored.

Bupa has responded to the media scrutiny by saying they were just reminding doctors to consider preventive care – emphasising that patients’ needs, doctors’ clinical judgement, and Medicare compliance come first.

But doctors are already wary.

A Healthed survey of almost 1500 GPs in September showed that two-thirds of GPs were uncomfortable with insurer ownership of clinics – with most of the remaining third undecided.

Six out of 10 GPs in the survey think that insurer ownership threatens the clinical independence of GPs. Breaking it down, 43% strongly agreed with that statement, while 18% slightly agreed – 14% were neutral, 13% were unsure, 7% strongly disagreed and 5% slightly disagreed). Reduced GP autonomy was the most common concern GPs raised.

“Under no circumstances should a health insurer be permitted to own a GP clinic! This is vertical integration and is profit driven and not patient driven,” one GP in the survey commented.

The Bupa email is just one example of corporate conflict of interest.

The ACCC also released its 2025-26 private health insurance report to the senate, bringing more light to unscrupulous and anti-competitive practices of insurers. Bupa features prominently in the report; in December it was ordered to pay $35 million in penalties for “engaging in unconscionable conduct and making false or misleading representations to Bupa members, hospitals and medical providers about entitlements to private health insurance benefits.”

Between 2018 and 2023 the company rejected the entire claim in cases where part of a patient’s hospital treatment was covered by their policy and part was not covered. This resulted in some patients cancelling, delaying or forgoing necessary treatments, and some doctors and hospitals not receiving the payments they were entitled to, the ACCC report said.

More broadly, the ACCC said that compared to the previous financial year, it had received 32% more enquires and reports about private health insurance, mostly regarding potential false representations or misleading conduct.

The AMA is renewing its call for an independent authority to oversee PHI. It said the decision over whether a patient needs a care plan should be based on a GPs clinical judgement, “not a revenue target,” adding that the story “highlights why we are so concerned about vertical integration in the private health insurance sector, and builds upon issues highlighted in the ACCC report,” regarding insurer behaviour.

What GPs are saying:

The following comments about private health insurer ownership of clinics are from Healthed’s September 2026 survey, conducted before the ACC report or ABC story were published:

“How much more evidence is required about potential conflict of interests?!”

“Private health insurer involvement in primary care is the beginning of the end of good quality equitable, accessible, patient care.”

“My previous experience with large corporates buying Ophthalmology practices was a very clear example of how this does no service to the future doctors. Pharmacies have also followed this path, with no service to the pharmacist, just the owner and the bigger company.”

“Ethical and professional standards are overlooked in favour of exploiting the profession for corporate profit.”

“I love to believe they are altruistic but let us be honest, they are businesses and even public clinics are politically driven so no entity is entirely innocent.”

“I think private health insurers and private equity in general practice is unlikely to be a good mix. If the primary goal is not to provide evidence based, holistic, patient-centred health care that also considers wider public health, then it is not going to be an effective health system. If finances and black and white KPIs are the focus, the benefit of quality primary care will be lost.”

“It’s just a business opportunity and nothing to do with the greater good.”

“Any pretence at the greater good or genuine care for patient wellbeing will simply be spin that no doubt will become increasingly apparent with time, as cost saving and profit driving gain a greater foothold.”

Have a perspective to share on this article? Email editor@healthed.com.au

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Ted Wu

Dr Ted Wu

Oral GLP1s – What GPs Need to Know

Dr Paige Lanyon-Roberts

Dr Paige Lanyon-Roberts

The New Oral Medications for Obesity – A Practical Guide for GPs

Dr Katherine Spira

Dr Katherine Spira

Menstrual Migraine

Prof Danny Green

Prof Danny Green

GLP1s and Muscle Mass – What Does the Evidence Show?

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Lynnette Hoffman

writer

Lynnette Hoffman

Managing Editor

Test your knowledge

Recent articles

Latest GP poll

In general, how comfortable do you feel about insurer ownership of GP clinics?

Very uncomfortable

0%

Somewhat uncomfortable

0%

Somewhat comfortable

0%

Very comfortable

0%

Undecided

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.